Mitochondrial RNA/RIG-I promotes Caspase-1/GSDMD-mediated inflammation in sepsis-associated acute kidney injury

Jie Jiao1, Xuan Fang1, Lisha Ma1

  • 1Laboratory of Cell Electrophysiology, Wannan Medical College, Anhui, China.

Immunobiology
|June 12, 2025
PubMed

Insights

Mitochondrial RNA (mtRNA) activates RIG-I, initiating inflammation in acute kidney injury (AKI). This mtRNA/RIG-I pathway drives AKI pathogenesis via Caspase-1 and GSDMD, highlighting a novel therapeutic target.

Area of Science:

  • Cell Biology
  • Immunology
  • Nephrology

Background:

  • Mitochondria are crucial in acute kidney injury (AKI) pathogenesis.
  • The precise mechanisms of mitochondrial regulation of inflammation in AKI are not fully understood.
  • Investigating mitochondrial RNA (mtRNA) and RIG-I in sepsis-induced renal injury is critical.

Purpose of the Study:

  • To elucidate the role of mitochondrial RNA (mtRNA) and retinoic acid-inducible gene I (RIG-I) in sepsis-induced renal injury.
  • To determine the interaction between mtRNA and RIG-I in the context of AKI.
  • To explore the downstream inflammatory signaling cascade involving Caspase-1 and GSDMD.

Main Methods:

  • Established a lipopolysaccharide-induced AKI mouse model.
  • Treated NRK-52E cells with lipopolysaccharide, ATP, and Nigericin (LAN).
  • Utilized Western blotting, immunohistochemistry, RNA immunoprecipitation, and co-immunoprecipitation.

Main Results:

  • Upregulation of RIG-I expression and cytoplasmic mtRNA elevation observed in AKI.
  • Demonstrated direct binding of mtRNA to RIG-I, inducing mitochondrial dysfunction.
  • mtRNA-induced mitochondrial damage and inflammation were mitigated by RIG-I knockdown.
  • Identified Caspase-1 and ASC association with RIG-I.
  • GSDMD knockout attenuated renal injury and reduced pro-inflammatory cytokines.

Conclusions:

  • The mtRNA/RIG-I axis is a key driver of inflammation in AKI.
  • This pathway involves Caspase-1 and GSDMD, leading to renal injury.
  • Targeting the mtRNA/RIG-I signaling pathway presents a potential therapeutic strategy for AKI.